Common drug evaluation of pregnancy with liver disease

doi:10.3877/cma.j.issn.2095-3259.2014.03.009

Abstract

Abstract:

Pregnancy with liver disease is a quite serious complication. Hepatic protection drugs play an important role in the treatment of liver disease, such as reducing liver enzyme, accelerating detoxification and energy metabolism, improving microcirculation and optimizing immune response, etc. This article mainly summarized 8 kinds of hepatic protection drugs and the rational use in pregnancy.

Key words: Pregnancy, high-Risk, Liver diseases, Hepatoprotectant drug

Pengzhi Zhou, Yaying Chen. Common drug evaluation of pregnancy with liver disease[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(03): 186-189.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2014.03.009

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2014/V03/I03/186

References 24

[1]	李小毛，周水生. 晚期妊娠合并重型肝炎的产科处理[J]. 中国实用妇科与产科杂志，2011, 27(2):106-109.
[2]	邬亚妙. 多烯磷脂酰胆碱(易善复)胶囊对妊娠合并慢性乙型肝炎的疗效[J]. 实用临床医药杂志，2007, 11(5):104-104.
[3]	胡国平，刘凯，赵连三. 多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J]. 肝脏，2005, 10(1):5-7.
[4]	黄慧萍. MIMS消化系统疾病用药指南[M]. 7版. 上海：美迪医讯亚太有限公司，2013：313-314.
[5]	Korenaga M, Hidaka I, Nishina S, et al. A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice[J]. Liver International, 2011, 31(4): 552-560.
[6]	Sun QF, Ding JG, Wang XF, et al. Efficacy and safety of intravenous stronger neo-minophagen C and S-adenosyl-L-methionine in treatment of pregnant woman with chronic hepatitis B: A pilot study[J]. Med Sci Monit, 2010, 16(8): PR9-14.
[7]	高悠婷，陈威，孙庆丰，等. 复方甘草酸苷注射液治疗妊娠晚期慢性乙肝患者对婴幼儿生长发育的影响[J]. 浙江医学，2013, (12): 1165-1167.
[8]	Anstee QM, Day CP. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility[J]. J Hepatol, 2012, 57(5):1097-109.
[9]	孔秋芹. 腺苷蛋氨酸治疗妊娠期肝内胆汁淤积症的文献分析[J]. 中国药业，2011, 20(9): 10-13.
[10]	俞丁丁. 不同剂量S-腺苷蛋氨酸对重度妊娠期肝内胆汁淤积症的疗效观察[J]. 临床合理用药杂志，2011, 4(16):57-58.
[11]	Ikebuchi Y, Shimizu H, Ito K, et al. Ursodeoxycholic acid stimulates the formation of the bile canalicular network[J]. Biochem Pharmacol, 2012, 84(7): 925-935.
[12]	常青，王静波，陈勇，等. 熊脱氧胆酸，地塞米松，思美泰对抗孕大鼠肝内胆汁淤积症的比较研究[J]. 第三军医大学学报，2004, 26(12):1091-1093.
[13]	蒋苏梅. 熊去氧胆酸联用思美泰对妊娠期肝内胆汁淤积症患者生化指标及瘙痒程度的影响[J]. 中国药业，2013, 22(23):19-20.
[14]	张晓燕. 多烯磷脂酰胆碱联合促肝细胞生长素治疗妊娠合并乙型肝炎临床疗效[J]．医学信息，2009, 22(8):1654.
[15]	宋育林，许建明. 常用保肝药的临床疗效评价和合理应用[J]. 胃肠病学，2007, 12(12):766-769.
[16]	吴淑云，侯志文，李岩. 联苯双酯引起肝损害加重[J]. 药物不良反应杂志，2008, 10(5):363-363.
[17]	卢书伟，蔡皓东. 联苯双酯临床适应证的探讨[J]. 药物不良反应杂志，2004, 2(4):225-228.
[18]	Liu G T, Li Y, Wei H L, et al. Toxicity of novel anti-hepatitis drug bicyclol: a preclinical study[J]. World J Gastroenterol, 2005, 11(5):665-671.
[19]	林国贤，黄庆华，林玉英，等. 双环醇治疗妊娠合并肝功能异常患者的疗效及安全性[J]. 肝脏，2013, 18(10):680-682.
[20]	Rajnarayana K, Reddy MS, Vidyasagar J, et al. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole[J]. Arzneimittelforschung, 2004, 54(2):109-113.
[21]	Wei F, Liu SK, Liu XY, et al. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B[J]. Eur J Clin Microbiol Infect Dis, 2013, 32(5):657-669.
[22]	王友俊. 水飞蓟素联合复方甘草酸苷治疗妊娠合并慢性乙型肝炎的疗效观察[J]. 中国医药，2012, 7(8):980-987.
[23]	范丽梅，徐立堃，张兰，等. 茵陈多糖对妊娠胆汁淤积大鼠肝脏氧化损伤的保护作用研究[J]. 中国医药导报，2013, 10(7):11-13.
[24]	陈友英，倪新红，梁国强，等. 中西医结合治疗肝内胆汁淤积症对妊娠结局的影响[J]. 世界中医药，2013(9):1058-1059.

Please choose a citation manager

Content to export